The inhibitory effect of nicotinamide on asthma-like symptoms and eosinophilia in guinea pigs, anaphylactic mast cell degranulation in mice, and histamine release from rat isolated peritoneal mast cells by compound 48-80.
D000336:Aerosols; D000707:Anaphylaxis / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D000818:Animals; D000941:Antigens / Q000008:administration & dosage; D001249:Asthma / Q000188:drug therapy*; D004802:Eosinophilia / Q000209:etiology; D006168:Guinea Pigs; D006636:Histamine Release / Q000187:drug effects; D008407:Mast Cells / Q000032:analysis / Q000187:drug effects* / Q000276:immunology; D009243:NAD / Q000032:analysis; D009536:Niacinamide / Q000627:therapeutic use*; D010047:Ovalbumin / Q000276:immunology; D003189:p-Methoxy-N-methylphenethylamine / Q000494:pharmacology
D000336:Aerosols; D000941:Antigens; D009243:NAD; D009536:Niacinamide; D003189:p-Methoxy-N-methylphenethylamine; D010047:Ovalbumin